Find the latest options here. They review the current management algorithm, emphasizing the importance of confirming castrate status and proper staging. Because any treatment for advanced disease remains palliative, patients with advanced prostate cancer should be encouraged to participate in clinical trials Docetaxel and prednisone in combination are currently considered the standard of care for men with crpc with detectable metastatic disease. Abstract background innovations in imaging and molecular characterisation together with novel treatment options have improved outcomes in advanced prostate cancer Summary purpose the management of advanced prostate cancer is rapidly evolving
WATCH
